Tong Xu

Tong Xu

Auto-generated profile, based on publicly available information

Tong Xu

Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College Hangzhou China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Cancer Letters
Verified
Journal Article
Closed access
ZPZongfu Pan
Zongfu Pan
QFQilu Fang
Qilu Fang
LLLu Li
Lu Li
YZYiwen Zhang
Yiwen Zhang
TXTong Xu
Tong Xu
MGMinghua Ge
Minghua Ge

18 March 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
TJTiefeng Jin
Tiefeng Jin
LDLingling Ding
Lingling Ding
JCJinming Chen
Jinming Chen
XZXiaozhou Zou
Xiaozhou Zou
TXTong Xu
Tong Xu
MGMinghua Ge
Minghua Ge
Chromosome instability (CIN) is a common contributor driving the formation and progression of anaplastic thyroid cancer (ATC), but its mechanism remains unclear. The BUB1 mitotic checkpoint serine/threonine kinase (BUB1) is responsible for the alignment of mitotic chromosomes, which has not been thoroughly studied in ATC. Our research demonstrated that BUB1 was remarkably upregulated and closely related to worse progression‐free survival. Knockdown of BUB1 attenuated cell viability, invasion, migration and induced cell cycle arrests, whereas overexpression of BUB1 promoted the cell cycle progression of papillary thyroid cancer cells. BUB1 knockdown remarkably repressed tumour growth and tumour formation of nude mice with ATC xenografts and suppressed tumour metastasis in a zebrafish xenograft model. Inhibition of BUB1 by its inhibitor BAY‐1816032 also exhibited considerable anti‐tumour activity. Further studies showed that enforced expression of BUB1 evoked CIN in ATC cells. BUB1 induced CIN through phosphorylation of KIF14 at serine1292 (Ser1292). Overexpression of the KIF14ΔSer1292 mutant was unable to facilitate the aggressiveness of ATC cells when compared with that of the wild type. Collectively, these findings demonstrate that the BUB1/KIF14 complex drives the aggressiveness of ATC by inducing CIN.

17 August 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
TXTong Xu
Tong Xu
WZWanli Zhang
Wanli Zhang
YZYi-Wen Zhang
Yi-Wen Zhang
FSFeifeng Song
Feifeng Song
PHPing Huang
Ping Huang
Anaplastic thyroid cancer (ATC), an aggressive malignancy with virtually 100% disease‐specific mortality, has long posed a formidable challenge in oncology due to its resistance to conventional treatments and the severe side effects associated with current regimens such as doxorubicin chemotherapy. Consequently, there was urgent need to identify novel candidate compounds that could provide innovative therapeutic strategies for ATC. Ophiopogonin D′ (OPD'), a triterpenoid saponin extracted, yet its roles in ATC has not been reported. Our data demonstrated that OPD' potently inhibited proliferation and metastasis of ATC cells, promoting cell cycle arrest and apoptosis. Remarkably, OPD' impeded growth and metastasis of ATC in vitro and in vivo, displaying an encouraging safety profile. Regulator of G‐protein signalling 4 (RGS4) expression was significantly up‐regulated in ATC compared to normal tissues, and this upregulation was suppressed by OPD' treatment. Mechanistically, we elucidated that the transcription factor JUN bound to the RGS4 promoter, driving its transactivation. However, OPD' interacted with JUN, attenuating its transcriptional activity and thereby disrupting RGS4 overexpression. In summary, our research revealed that OPD' bound with JUN, which in turn resulted in the suppression of transcriptional activation of RGS4, thereby eliciting cell cycle arrest and apoptosis in ATC cells. These findings could offer promise in the development of high‐quality candidate compounds for treatment in ATC.

2 April 2025 in The FASEB Journal
Verified
Journal Article
Closed access
TXTong Xu
Tong Xu
WZWanli Zhang
Wanli Zhang
SGShaobo Gong
Shaobo Gong
BJBo Jiang
Bo Jiang
ZFZhiyi Fu
Zhiyi Fu
PHPing Huang
Ping Huang

22 September 2025 in The FASEB Journal
Verified
Journal Article
Closed access
YZYe Zhi
Ye Zhi
LGLuqi Ge
Luqi Ge
SWShaoru Wang
Shaoru Wang
WZWencong Zang
Wencong Zang
ZZZhentao Zhang
Zhentao Zhang
PHPing Huang
Ping Huang

12 June 2025 in The FASEB Journal
Verified
Journal Article
Closed access
FSFeifeng Song
Feifeng Song
QZQi Zhang
Qi Zhang
ZZZhentao Zhang
Zhentao Zhang
TXTong Xu
Tong Xu
HQHui Qin
Hui Qin
PHPing Huang
Ping Huang